Literature DB >> 8357876

Modified high-performance liquid chromatographic method for analysis of drotaverine in human plasma.

J K Lalla1, M U Shah, M B Jain, A H Sharma.   

Abstract

An HPLC method is described for the determination of drotaverine in plasma; papaverine is used as the internal standard. The lower limit of quantitation is 50 ng ml-1 with an inter-assay precision (RSD) of below 4%. The method has been validated and successfully used to assay clinical trial samples in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8357876     DOI: 10.1016/0731-7085(93)80033-w

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Pharmacokinetics and bioavailability of drotaverine in humans.

Authors:  O O Bolaji; C O Onyeji; A O Ogundaini; T A Olugbade; F A Ogunbona
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

2.  Simultaneous spectrophotometric determination of drotaverine hydrochloride and paracetamol in tablet.

Authors:  Sonali Mahaparale; R S Telekone; R P Raut; S S Damle; P V Kasture
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.